SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?Article Published on 2022-09-012022-11-15 Journal: The journal of allergy and clinical immunology. In [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] addition Antibody evasion appear caused COVID-19 COVID-19 infection COVID-19 vaccine CVID dawn deaths End Fatality rate form group healthy individuals Hospitalization immunodeficiency immunodeficient patients implication individual innate immune less LIGHT Long lung damage morbidity offer offered omicron outcomes pandemic Patient Perspective physical Psychiatric reduced risk respond risk SARS-CoV-2 SARS-CoV-2 variants severe disease survivor T-cell the SARS-CoV-2 those with comorbidity Tunnel variant [DOI] 10.1016/j.jaip.2022.06.011 PMC 바로가기
COVID-19 vaccination, incidence, and mortality rates among indigenous populations compared to the general population in Brazil: Describing trends over timeResearch article Published on 2022-09-012022-10-05 Journal: The Lancet Regional Health - Americas [Category] 진단, [키워드] absence Adults age available data Brazil chronic Coverage COVID-19 COVID-19 incidence COVID-19 pandemic COVID-19 vaccination cumulative cumulative mortality death decrease Describing detrimental Effectiveness extreme finding funding General population health inequities Health inequity heterogeneity implementation incidence incidence rate incidence rates Indigenous populations information Isolation Ministry of Health Mortality mortality rate Older Population populations regions reported resource respond supported the vaccine Trends over time vaccination Vaccination strategy Vaccine [DOI] 10.1016/j.lana.2022.100319 [Article Type] Research article
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell TransplantationArticle Published on 2022-09-012022-11-16 Journal: Transplantation and cellular therapy [Category] COVID19(2023년), SARS, 치료기술, [키워드] age Allogeneic allogeneic transplantation antibody Antibody Response average binding antibody unit Blood donors BNT162b2 chronic GVHD CORD COVID-19 detectable Donor dose Efficacy Graft-versus-host disease GVHD in vivo independent predictor initial involved JNJ-78436735 Johnson & Johnson less Lymphocyte count lymphocyte counts Moderna mRNA-1273 multivariable analysis Patient Predictive Prophylaxis question recipient recipients respond response robust SARS-CoV-2 spike protein SARS-CoV-2 vaccination Serologic response STEM stem cell Stem cell transplantation T cell depletion T-cell T-cell Depletion Transplant transplantation transplants umbilical cord blood vaccination Vaccine [DOI] 10.1016/j.jtct.2022.06.012 PMC 바로가기
Strategic purchasing and health systems resilience: Lessons from COVID-19 in selected European countriesReview article Published on 2022-09-012022-10-05 Journal: Health policy (Amsterdam, Netherlands) [Category] 신약개발, [키워드] conducted Contracting contributed country COVID-19 COVID-19 pandemic creating defined Efficiency European European country European health systems Features Government health system health systems Health systems resilience lesson pandemic Payers Purchasing Research respond selected Seven [DOI] 10.1016/j.healthpol.2022.06.005 [Article Type] Review article
Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concernArticle Published on 2022-09-012022-11-15 Journal: Immunological reviews [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome African antigenic assays B cell cause Combination coronavirus coronavirus disease COVID-19 cross-reactive cross-reactive antibodies driving elicited Epidemic Frequency genomic highlight HIV HIV vaccine Hybrid immunity immune response Immunity immunogenic immunological immunology Infection mutated variants pandemic platform population immunity Prevent Region Research respiratory viruses respond response responses SARS-CoV-2 SARS-CoV-2 immunity shown South Surveillance the SARS-CoV-2 to define triggered vaccination Vaccine variants variants of concern virus VoC [DOI] 10.1111/imr.13086 PMC 바로가기
Effective Approaches to Study the Genetic Variability of SARS-CoV-2Article Published on 2022-08-242022-11-16 Journal: Viruses [Category] SARS, 변종, [키워드] appears approach bioinformatics coronavirus country COVID-19 pandemic determine diagnostic diagnostic procedure effective Effective vaccines Effectiveness effort false negative result Genetic variant identify information involved Laboratory measure multiplex Multiplex PCR NGS Novel coronavirus nucleic acid amplification pathogen producing protocols reduce respond risk Russia SARS-CoV-2 SARS-CoV-2 variant sequence Sequencing several variant Significant therapy Transmissibility Treatment Vaccines variant viral genomes virus virus variants [DOI] 10.3390/v14091855 PMC 바로가기
Human coronaviruses disassemble processing bodiesArticle Published on 2022-08-232022-11-16 Journal: PLoS Pathogens [Category] SARS, 유전자 메커니즘, [키워드] 229E caused cells characteristic common cold CoVs contribute coronavirus Coronavirus infection correlated CoVs cytokine cytoplasmic dysregulated dysregulation expression FIVE fluorescent Granule Human human coronavirus IL-6 immune response impacted infected cell Infection information innate immune response mechanism MERS mRNA transcripts NL63 OC43 processing Proinflammatory cytokine proinflammatory cytokines promote Protein respond responsible ribonucleoprotein RNA RNAs SARS-CoV SARS-CoV-2 SARS-CoV-2 N SARS-CoV-2 N protein screened severe SARS-CoV-2 stability submission the N protein the viral nucleocapsid TNF transcript translation unique viral infection virus [DOI] 10.1371/journal.ppat.1010724 PMC 바로가기
Current status and capacity of pathogen laboratories in centers for disease control and prevention in China during the COVID-19 pandemic: A nationwide cross-sectional surveyArticle Published on 2022-08-112022-11-15 Journal: Frontiers in Public Health [Category] SARS, 치료기술, [키워드] Capacity CDC cDCs Centers for Disease Control and Prevention China Chinese CDC conducted COVID-19 COVID-19 pandemic cross-sectional cross-sectional survey current difference disease equipment infectious disease outbreak Influenza key factor Laboratory lack MOST pathogen pathogen laboratory. public health reported respiratory virus respond SARS-CoV-2 sequencing technology [DOI] 10.3389/fpubh.2022.927318 PMC 바로가기
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall ResponseSARS-CoV-2 감염 및 백신 회수 반응 이후 중간 기억 B 세포의 지속적인 유지Article Published on 2022-08-102022-09-12 Journal: Journal of Virology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] analyzed antibodies antibody Antigen B cell B cell response booster CD21 CD27 CD4 CD4+ CD4+ T cell Cell correlated COVID-19 demonstrated determine elicited help highlight immune response Immunity immunization individual level infected individual Infection intermediate Kinetics Longevity longitudinal maintain maintenance memory B memory B cell memory B cells neutralization Neutralizing antibodies neutralizing antibody Pandemics persistence persistent phenotype Postinfection Protective Protein recall receptor recovered respond response SARS-CoV-2 SARS-COV-2 infection secreted significantly spike T cells the SARS-CoV-2 triggered vaccination [DOI] 10.1128/jvi.00760-22 PMC 바로가기 [Article Type] Article
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variantsSARS-CoV-2 Alpha, Beta, Gamma, Delta 및 Kappa 변이체에 대한 BNT162b2 백신을 완전히 접종한 개인의 혈청/IgG 제제 중화 활성Article Published on 2022-08-082022-09-11 Journal: Scientific Reports [Category] SARS, 변종, 진단, 치료제, [키워드] (alpha administration Alpha antiviral activity approach Beta BNT162b2 BNT162b2 vaccine caused change COVID-19 pandemic Delta delta variant Effectiveness examined fraction Gamma General Hospital IgG individual Influenza influenza vaccines Japan Kumamoto long-lasting Moderation mRNA mRNA-based vaccine mutable Neutralizing activity of BNT162b2 pandemic Pathogens Prospective Study purified reduced reduction respond SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 variant sera vaccinated individual Vaccine variant variants wild-type SARS-CoV-2 Wuhan [DOI] 10.1038/s41598-022-17071-9 PMC 바로가기 [Article Type] Article